Search

You searched for "cosmeceutical"

79 results found

The 5 Rs of the renaissance. The new paradigm in aesthetic medicine

22 October 2024
The Renaissance was a period of great importance in human history where art and science came together to define ideal beauty. This same search for harmony is reflected in current aesthetic medicine, where proportion and symmetry are considered fundamental. For...

W-Wellness appoints Belinda Aloisio as Strategy and Sales Consultant Director

1 September 2025 | Recruitment & Personnel, Company Profiles
W-Wellness, the UK’s first expert-led wellness e-commerce platform, is delighted to announce the appointment of Belinda Aloisio as Strategy and Sales Consultant Director, further strengthening its dynamic leadership team. With close to two decades of experience in the aesthetic beauty...

What’s new on the horizon for toxins coming to the market?

1 February 2019 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
With the ever increasing demand for injectable treatments, it is important to keep abreast of new developments in the field. International expert Michael Gold reviews the new toxins due to be hitting the market in the next year. We are...

How I Do It - Contouring the lower jaw (surgical)

1 October 2014 | | PMFA - Facial Plastic Surgery
It is essential to clearly understand the patient’s needs so I usually see patients three to four times prior to operating if major changes to appearance are planned. You must also be able to manage expectations and postoperative outcomes; for...

In conversation with Amanda Cameron

8 November 2022 | PMFA - Aesthetic Medicine
We spoke to Amanda Cameron about her fascinating career in aesthetics, from her early clinical days as a nurse through to her experience in the field of publishing. You are legendary in the world of aesthetic nursing – can you...

Support groups for hidradenitis suppurativa

1 October 2015 | | PMFA - Dermatology
Hidradenitis suppurativa (HS) is an inflammatory condition characterised by painful inflamed nodules in the apocrine regions of the body. It follows a chronic relapsing clinical course and is a very difficult condition to treat. It has an estimated prevalence of...

Xanthelasma

1 April 2014 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Although the lesion known as Xanthelasma was first described by Addison and Gall in 1851 [1] it was recorded some 300 years previously in the famous painting of the Mona Lisa by Leonardo da Vinci. In this painting, Leonardo da...

Recent developments in hyaluronic acid research

5 February 2020 | | PMFA - Aesthetic Medicine, PMFA - Dermatology, PMFA - General Plastic Surgery
Hyaluronic acid has a role in many medical specialties, not just aesthetics. Anna Baker takes us through the latest evidence and therapeutic indications. The evidence and demand for hyaluronic acid (HA) based technologies continues to expand and evolve across a...

Online connections in a post-COVID world

2 August 2022 | | PMFA - Aesthetic Medicine
Looking back at the pandemic, it has brought us unexpected friendships. The lack of direct interpersonal communication, meetings, parties and hugs increased the role of digital sources of contact which used to play a less important role in our lives....

The flora of Culloden Field: Healing plants of a wounded land

2 June 2025 | | PMFA - General
The Battle of Culloden, fought on 16 April 1746, marked the end of the Jacobite uprising in Scotland. It was a devastating clash between the Jacobite forces led by Charles Edward Stuart (‘Bonnie Prince Charlie’) and the British army under...

In conversation with Professor David Sines

1 August 2018 | PMFA - Aesthetic Medicine, PMFA - Dermatology
In January 2016 a new voluntary regulatory register was established – the Joint Council for Cosmetic Practitioners (JCCP), chaired by Professor David Sines. Since that time the JCCP has met with challenges from many within the aesthetics industry. We spoke...

A short overview of the evolution of botulinum toxin type A formulations

1 June 2023 | | PMFA - Aesthetic Medicine, PMFA - Dermatology
Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...